CT (5 and 25 mg/kg, every other day by i.p. for four weeks) decreased tumor weight and the mRNA levels of AR-dependent transactional genes such as PSA and TMPRSS2 in 22Rv1 prostate cancer xenografts, all in dose-dependent manners [262]. This evidence concerns the gene KLK3 and neoplasm.